Founded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) supporting discovery and preclinical development of drugs. InnoSer’s mission is to accelerate drug development by offering well-characterized and accurate near-patient research models and innovative CRO-services. InnoSer's offering includes a proprietary PDX/O screening platform for oncology, a unique ADPKD mouse model for nephrology, as well as a first-in-class, fully characterized and validated, midbrain organoid model for Parkinson’s disease. InnoSer also provides in-vivo imaging, pathology and genetically engineered mice model services including colony management, cryopreservation, sanitation/rederivation.

Categorieën